Gangolli Julian S

CIK 00015320235 companiesNEWARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001532023

Recent Transactions

50 trades

Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2024-10-01+71,169→ 71,169 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2024-10-01+56,636→ 56,636 total
Award
Krystal Biotech, Inc.$KRYS
Stock Option (Right to Buy)
2024-06-30+5,000→ 5,000 total
Exercise/Conversion
Krystal Biotech, Inc.$KRYS
Stock Option (Right to Buy)
2024-05-20−20,000→ 0 total
Sale
Krystal Biotech, Inc.$KRYS
Common Stock
2024-05-20$163.71/sh−10,930→ 9,070 total
Exercise/Conversion
Krystal Biotech, Inc.$KRYS
Common Stock
2024-05-20$22.75/sh+20,000→ 20,000 total
Sale
Krystal Biotech, Inc.$KRYS
Common Stock
2024-05-20$164.34/sh−7,090→ 1,980 total
Sale
Krystal Biotech, Inc.$KRYS
Common Stock
2024-05-20$165.76/sh−1,980→ 0 total
Award
Revance Therapeutics, Inc.
Common Stock
2024-05-01+15,000→ 45,106 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2024-05-01+23,458→ 23,458 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2024-03-07+94,441→ 94,441 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2023-10-04+370,282→ 370,282 total
Award
Krystal Biotech, Inc.$KRYS
Stock Option (Right to Buy)
2023-06-30+6,800→ 6,800 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2023-05-03+5,915→ 5,915 total
Award
Revance Therapeutics, Inc.
Common Stock
2023-05-03+3,534→ 30,106 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2023-03-29+41,065→ 41,065 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2022-10-05+74,398→ 74,398 total
Award
Krystal Biotech, Inc.$KRYS
Stock Option (Right to Buy)
2022-06-30+6,800→ 6,800 total
Award
Revance Therapeutics, Inc.
Common Stock
2022-05-04+6,059→ 26,572 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2022-05-04+10,756→ 10,756 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2022-05-04+11,343→ 11,343 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2022-03-23+21,878→ 21,878 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2021-10-05+44,466→ 44,466 total
Award
Krystal Biotech, Inc.$KRYS
Stock Option (Right to Buy)
2021-06-30+6,800→ 6,800 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2021-05-05+7,551→ 7,551 total
Award
Revance Therapeutics, Inc.
Common Stock
2021-05-05+4,013→ 20,513 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2021-03-24+20,873→ 20,873 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2020-10-05$0.51/sh+150,748→ 150,748 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2020-07-17+125,000→ 125,000 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2020-07-01$0.99/sh+35,006→ 35,006 total
Award
Krystal Biotech, Inc.$KRYS
Stock Option (Right to Buy)
2020-06-30+6,800→ 6,800 total
Award
Revance Therapeutics, Inc.
Common Stock
2020-05-14+6,000→ 16,500 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2020-05-14+12,000→ 12,000 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2020-04-20+25,000→ 25,000 total
Sale
GW PHARMACEUTICALS PLC
Ordinary Shares
2019-05-10$14.63/sh−117,876→ 660,600 total
Exercise/Conversion
GW PHARMACEUTICALS PLC
Stock Options
2019-05-10−10,788→ 0 total
Exercise/Conversion
GW PHARMACEUTICALS PLC
Stock Options
2019-05-10−75,369→ 0 total
Exercise/Conversion
GW PHARMACEUTICALS PLC
Stock Options
2019-05-10−192,755→ 0 total
Exercise/Conversion
GW PHARMACEUTICALS PLC
Stock Options
2019-05-10−6→ 10,603 total
Exercise/Conversion
GW PHARMACEUTICALS PLC
Ordinary Shares
2019-05-10$0.00/sh+403,804→ 510,352 total
Exercise/Conversion
GW PHARMACEUTICALS PLC
Ordinary Shares
2019-05-10$10.61/sh+75,369→ 585,721 total
Exercise/Conversion
GW PHARMACEUTICALS PLC
Ordinary Shares
2019-05-10$3.72/sh+192,755→ 778,476 total
Sale
GW PHARMACEUTICALS PLC
Ordinary Shares
2019-05-10$14.70/sh−81,156→ 579,444 total
Sale
GW PHARMACEUTICALS PLC
Ordinary Shares
2019-05-10$14.80/sh−65,268→ 514,176 total
Sale
GW PHARMACEUTICALS PLC
Ordinary Shares
2019-05-10$14.88/sh−208,260→ 305,916 total
Sale
GW PHARMACEUTICALS PLC
Ordinary Shares
2019-05-10$14.96/sh−145,164→ 160,752 total
Sale
GW PHARMACEUTICALS PLC
Ordinary Shares
2019-05-10$15.03/sh−12,048→ 148,704 total
Sale
GW PHARMACEUTICALS PLC
Ordinary Shares
2019-05-10$15.12/sh−31,368→ 117,336 total
Sale
GW PHARMACEUTICALS PLC
Ordinary Shares
2019-05-10$15.19/sh−10,788→ 106,548 total
Exercise/Conversion
GW PHARMACEUTICALS PLC
Stock Options
2019-05-10−27,419→ 0 total

Companies

Recent Filings

Address

C/O REVANCE THERAPEUTICS, INC. 7555 GATEWAY BOULEVARD

NEWARK, CA, 94560

View on SEC.gov